Clinical features and physiotherapy management for COVID-19 in children

Paulo A Magalhães1, Fernanda Lanza2, Bárbara Bernardo Figueiredo3

  • 1Research Group of Neonatal and Pediatric Physical Therapy, Baby GrUPE, Postgraduate Program in Rehabilitation and Functional Performance, Department of Physical Therapy, University of Pernambuco, Petrolina, Brazil - paulof.magalhaes@upe.br.

Minerva Pediatrics
|October 27, 2020
PubMed

Insights

Physiotherapy for children with COVID-19 focuses on respiratory support and early mobilization. This approach aims to manage functional limitations and improve recovery from the viral infection.

Area of Science:

  • Pediatric Respiratory Medicine
  • Infectious Diseases
  • Rehabilitation Sciences

Background:

  • COVID-19 presents a global health challenge, impacting various aspects of life.
  • Limited research exists on the clinical-functional presentation and physiotherapy management of COVID-19 in children.
  • This review synthesizes current evidence on physiotherapy interventions for pediatric COVID-19 cases.

Approach:

  • A systematic review of literature published between January 1 and March 26, 2020.
  • Searched major databases including PubMed/Medline, SciELO, and PEDro.
  • Utilized keywords related to COVID-19 and SARS-CoV-2, analyzing results through the International Classification of Functioning, Disability and Health (ICF).

Key Points:

  • COVID-19 can restrict participation in activities and impair respiratory function and exercise tolerance in children.
  • Personal protective equipment and contact precautions are crucial components of care.
  • Immediate oxygen therapy for hypoxia is vital, with advanced respiratory support (e.g., nasal high-flow oxygen, noninvasive ventilation, prone positioning) indicated when necessary.
  • Airway clearance techniques should be used judiciously, and early mobilization is encouraged.

Conclusions:

  • Physiotherapy interventions for pediatric COVID-19 include ventilatory management, airway clearance, and early activity/mobilization.
  • These interventions are essential for addressing the functional consequences of the virus in children.
  • Evidence-based physiotherapy supports the comprehensive management of children affected by COVID-19.
Abstract

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.9K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.6K
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
326
Pleural Effusion II: Symptoms and Management01:28

Pleural Effusion II: Symptoms and Management

Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
446
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
582
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.0K